P651: VENETOCLAX-BASED TREATMENT OF PATIENTS WITH RICHTER SYNDROME: OUTCOMES FROM A MULTICENTER RETROSPECTIVE STUDY

• P. Hampel,
• S. Parikh,
• W. Wierda,
• A. Ferrajoli,
• N. Jain,
• J. Burger,
• T. Call,
• Y. Wang,
• S. Kenderian,
• W. Ding,
• P. Thompson

Affiliations

P. Hampel

1 Hematology, Mayo Clinic, Rochester

S. Parikh

1 Hematology, Mayo Clinic, Rochester

W. Wierda

2 Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, United States of America

A. Ferrajoli

2 Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, United States of America

N. Jain

2 Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, United States of America

J. Burger

2 Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, United States of America

T. Call

1 Hematology, Mayo Clinic, Rochester

Y. Wang

1 Hematology, Mayo Clinic, Rochester

S. Kenderian

1 Hematology, Mayo Clinic, Rochester

W. Ding

1 Hematology, Mayo Clinic, Rochester

P. Thompson

2 Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, United States of America